Axel S. Merseburger, Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig Holstein, shared a post on X:
“New on Medudy: Androgen Receptor Ligand-Directed Degraders (ARLDDs) and the rechARge study, offering practical insights into a novel therapeutic approach for patients with mCRP.”
Read the full article on Medudy.
More posts from Axel S. Merseburger.